#59: ACTC News Advanced Cell's Robert Lanza, M.D. Will Speak on 'Promise: The Future of Stem Cells' Wednesday, March 28, 2007 at 7:30 PM at Quinnipiac University in Hamden, CT, Presented by StemConn 2007
ALAMEDA, Calif.--(BUSINESS WIRE)--Advanced Cell Technology, Inc.’s (OTCBB: ACTC) Robert Lanza, M.D., VP of Research and Scientific Development, will participate in a panel...
#58: ACTC News Advanced Cell's Michael D. West, Ph.D., to Speak at 3rd Annual Stem Cell Research and Therapeutics Summit on ``Strategies for the Accelerated Development of Therapeutics from hES Cells''
ALAMEDA, Calif.--(BUSINESS WIRE)--Advanced Cell Technology, Inc.’s (OTCBB: ACTC) Michael D. West, Ph.D., President and Chief Scientific Officer, will discuss “Strategies for...
ALAMEDA, Calif.--(BUSINESS WIRE)--Preclinical studies using hESCs derived from Advanced Cell Technology, Inc.’s (OTCBB: ACTC) proprietary ACTcellerate technology (a means of...
#56: ACTC News Advanced Cell Technology Executives to Discuss ``The Business of Stem Cells'' and Participate in ``Conversations with Experts'' at The Stem Cell Meeting Hosted by Burrill and Company at UCSF
ALAMEDA, Calif.--(BUSINESS WIRE)--Advanced Cell Technology, Inc.’s (OTCBB: ACTC) William M. Caldwell, IV, Chairman and CEO, will discuss “The Business of Stem Cells”...
ALAMEDA, Calif.--(BUSINESS WIRE)--Advanced Cell Technology, Inc.’s (OTCBB: ACTC) ability to rescue vision in blind rats was noted in Scientific American’s March 2007 issue...
ALAMEDA, Calif.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (OTCBB: ACTC) applauds the $3 Billion Stem Cell Research Program, Proposition 71, upheld Monday by a California appeals...
#52: ACTC News Advanced Cell's Michael West, Ph.D., Highlights ACTCellerate Platform, A Means of Accelerating the Differentiation of Cells from Human Embryonic Stem Cells, at 2nd Annual Stem Cell Summit
ALAMEDA, Calif.--(BUSINESS WIRE)--Advanced Cell Technology, Inc.’s (OTCBB: ACTC) Michael West Ph.D., President and Chief Scientific Officer highlighted the Company’s...
#51: ACTC News Advanced Cell Technology Names Noted Biotech Industry Executive Dr. Pedro Huertas, as Chief Development Officer to Manage the Clinical Development and Regulatory Approval Process for its Stem Cell-Based Therapeutic Products
ALAMEDA, Calif.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (OTCBB: ACTC) names Pedro Huertas, MD, PhD, as Chief Development Officer responsible for overseeing the development of...
ALAMEDA, Calif.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (OTCBB:ACTC),
applying proprietary human embryonic stem (ES) cell technology to the
emerging field of regenerative...
ALAMEDA, Calif.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (OTCBB:ACTC),
applying proprietary human embryonic stem (ES) cell technology to the
emerging field of regenerative...
ALAMEDA, Calif.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (OTCBB:ACTC),
applying proprietary human embryonic stem (ES) cell technology to the
emerging field of regenerative...
#47: ACTC News Advanced Cell Technology Announces Investor Conference Call to Be Held Friday January 19 to Discuss Key Events and Progress in Stem Cell-Based Therapeutic Programs
ALAMEDA, Calif.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (OTCBB:ACTC),
applying proprietary human embryonic stem (ES) cell technology to the
emerging field of regenerative...
ALAMEDA, Calif.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (OTCBB:ACTC),
applying proprietary human embryonic stem (ES) cell technology to the
emerging field of regenerative...
ALAMEDA, Calif.--(BUSINESS WIRE)--Advanced Cell Technology, Inc.’s (OTCBB: ACTC)
William M. Caldwell, IV, Chief Executive Officer, was interviewed on
CNBC Television’s...
